Year: 2019
Type: article
Abstract: The evolution of endovascular technology has made minimally invasive treatment of aortic pathology possible. Thoracic aortic injury is no exception with the advent of thoracic endovascular aortic repair (TEVAR). Since the approval of TEVAR for treatment of thoracic aneurysms, the indications for TEVAR have expanded to treatment of dissection and traumatic thoracic aortic injury. 1 Despite the absence of randomized clinical trials comparing open repair with TEVAR for traumatic thoracic aortic injury, TEVAR has eclipsed open repair and has been recommended as the preferential operative approach by the Society of Vascular Surgery guidelines (grade 2, level C). 2 Importantly, few studies have examined the long-term outcomes of treating traumatic thoracic aortic injury with TEVAR.
Source: JAMA Network Open
Institution: Michigan Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W2913270264
